Evidence map›Paper›PMID 10933048›Full record

ArticleNeoplasia (New York, N.Y.)1999

Induction and characterization of human glioma clones with different radiosensitivities.

J Wang, L Hu, N Gupta, T Shamseldin, T Ozawa, J Klem, M Cardell, D F Deen

Open access · goldAbstract read
In one paragraph

Article in Neoplasia (New York, N.Y.), 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact, top 93% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

J WangBrain Tumor Research Center of the Department of Neurological Surgery, School of Medicine, University of California, San Francisco 94143-0520, USA.
L Hu
N Gupta
T Shamseldin
T Ozawa
J Klem
M Cardell
D F Deen
Neurological Surgery · USUniversity of California, San Francisco · US

Funding

TREATMENT OF MALIGNANT BRAIN TUMORSP01CA013525 · NCI · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI DEEN, DENNIS F. · 1985 to 1999
–
NCI NIH HHS CA-13525
6 · The paper itself

Abstract

To facilitate investigation of the molecular mechanisms of tumor cell radiosensitivities, we have generated a set of clones with different radiosensitivities from a human glioma cell line U-251 MG-Ho. Forty-four colonies were isolated by subjecting parent cells to the mutagen N-methylnitrosourea and then irradiating these cells with increasing doses of x-rays. About half of the clones displayed different radiosensitivities than the parent cells. We selected one of the most sensitive clones (X3i) and one of the most resistant clones (Y6) for further study. Isoeffective doses for these two clones differed by about a factor of 1.7; the relative radiosensitivities of both clones were stable for at least 30 cell culture passages. These two clones do not differ significantly in either the induction or repair of radiation-induced DNA double-strand breaks as measured by pulsed field gel electrophoresis. Radiation-induced apoptosis measured by terminal deoxynucleotide transferase-mediated dUTP nick end labeling assay and micronucleus formation were similar in both clones. However, potentially lethal damage repair was greater in the radioresistant Y6 clone than in the radiosensitive X3i clone as determined by colony-forming efficiency assay.

Indexed as

Alkylating AgentsApoptosisCell Culture TechniquesCell SurvivalChromosomesDNA DamageDNA RepairDose-Response Relationship, RadiationGliomaHumansIn Situ Nick-End LabelingMethylnitrosoureaMicronucleus TestsRadiation ToleranceTime FactorsTumor Cells, CulturedAlkylating AgentsMethylnitrosourea

Identifiers

PMID10933048
PMCPMC1508132
OpenAlexW2010635405

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.